Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Annals of Surgical Oncology|June 22, 2014
Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvementStacy Ugras, Michelle Stempel, Sujata Patil, et al.Annals of Surgical Oncology|April 22, 2017
Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast CancerAnita Mamtani, Sujata Patil, Michelle Stempel, et al.Annals of Surgical Oncology|July 26, 2019
Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast CancersAnita Mamtani, Emily C Zabor, Michelle Stempel, et al.Annals of Surgical Oncology|June 25, 2016
Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer PatientsDamian McCartan, Michelle Stempel, Anne Eaton, et al.Journal of the American College of Surgeons|October 18, 2008
Reoperative sentinel lymph node biopsy after previous mastectomyAmer Karam, Michelle Stempel, Hiram S Cody, et al.Annals of Surgical Oncology|September 6, 2015
Oncotype DX in Bilateral Synchronous Primary Invasive Breast CancerMaria Karsten, Michelle Stempel, Julia Radosa, et al.Annals of Surgical Oncology|November 11, 2015
Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?Melissa Pilewskie, Starr Koslow Mautner, Michelle Stempel, et al.Annals of Surgical Oncology|July 17, 2015
Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed?Preeti Subhedar, Michelle Stempel, Anne Eaton, et al.The Breast Journal|September 25, 2015
Breast Cancer in the Elderly: Is MRI Helpful?Melissa Pilewskie, Allison Hirsch, Anne Eaton, et al.Annals of Surgical Oncology|August 9, 2008
Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?Alice Chung, Jeanne Yu, Michelle Stempel, et al.Pageof 7